Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Sees Significant Decline in Short Interest
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) was the target of a large decrease in short interest in the month of March. As of March 15th, there was short interest totalling 2,690,000 shares, a decrease of 11.5% from the February 29th total of 3,040,000 shares. Based on an average daily volume of 834,900 shares, […]
More Stories
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Short Interest Down 39.8% in November
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB – Get Free Report) saw a significant drop in short interest in the month of November....
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Short Interest Down 39.8% in November
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB – Get Free Report) saw a significant drop in short interest in the month of November....
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Short Interest Down 39.8% in November
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB – Get Free Report) saw a significant drop in short interest in the month of November....
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Short Interest Down 39.8% in November
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB – Get Free Report) saw a significant drop in short interest in the month of November....
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Short Interest Down 39.8% in November
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB – Get Free Report) saw a significant drop in short interest in the month of November....
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Short Interest Down 39.8% in November
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB – Get Free Report) saw a significant drop in short interest in the month of November....